Skip to content

Evaluation of ablation in the treatment of arrhythmia

Evaluation of the effect of ablation technique with radiofrequency waveforms in the treatment of supraventricular arrhythmia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160926029976N5
Enrollment
80
Registered
2019-06-09
Start date
2019-01-21
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraventricular tachyarrythmia. Supraventricular tachycardia

Interventions

Intervention group: After undergoing primary electrophysiologic examination to determine the type of supraventricular tachyarrhythmia and determine the target points, patients are subjected to ablatio

Sponsors

Vice Chancellor For Research, Babol University Of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Symptomatic, life-threatening tachyarrhythmia that is resistant to drug therapy Symptomatic, life-threatening tachyarrhythmia that has adverse effects of drug

Exclusion criteria

Exclusion criteria: Cardiac valvular disease Tachycardia period less than once a week Atrial fibrillation Pregnancy Atrial Flutter

Design outcomes

Primary

MeasureTime frame
Atrioventricular block. Timepoint: Evaluation of atrioventricular block 3 months after intervention. Method of measurement: Electrocardiogram.;Pneumothorax. Timepoint: Evaluation of pneumothorax 3 months after intervention. Method of measurement: Chest X ray.;Deep vein thrombosis. Timepoint: Evaluation of deep vein thrombosis 3 months after intervention. Method of measurement: Doppler ultrasonography of lower extremities.;Stroke. Timepoint: Evaluation of stroke 3 months after intervention. Method of measurement: physical examination and brain magnetic resonance imaging.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Akbarian

Babol University of Medical Sciences

Akbarian_mahsa@yahoo.com+98 11 3223 8301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026